他汀使用与骨关节炎及类风湿关节炎关节置换风险:倾向评分匹配纵向队列研究
该研究利用英国临床实践研究数据链,将178 467名他汀使用者与178 467名非使用者按年龄、性别、诊所和倾向评分匹配,评估他汀与膝或髋关节置换风险的关联。总体他汀使用与关节置换风险降低无关(HR 0.99,95%CI 0.97-1.03),但高强度他汀与风险降低相关(HR 0.86,95%CI 0.75-0.98),且该降低仅见于类风湿关节炎相关置换(HR 0.77,95%CI 0.63-0.94),骨关节炎相关置换无显著关联(HR 0.97,95%CI 0.94-1.01)。
要点
- 总体他汀使用未显著降低膝或髋关节置换风险(HR 0.99)。
- 高强度他汀与关节置换风险降低相关(HR 0.86)。
- 风险降低仅见于类风湿关节炎相关置换(HR 0.77),骨关节炎无显著关联。
核心结论
- 高强度他汀可能降低膝或髋关节置换风险,且该效应可能为类风湿关节炎特异性。
研究设计与样本
- 倾向评分匹配队列研究,使用英国临床实践研究数据链电子健康记录。
- 共匹配178 467名他汀使用者与178 467名非使用者,按年龄、性别、诊所和倾向评分匹配。
- 他汀暴露按低密度脂蛋白降低强度分为低(21-28%)、中(32-38%)、高(42-55%)强度。
- 主要结局为膝或髋关节置换总体及因骨关节炎或类风湿关节炎的置换,采用Cox比例风险回归分析。
主要发现
- 总体他汀使用与膝或髋关节置换风险降低无关(HR 0.99,95%CI 0.97-1.03)。
- 高强度他汀与关节置换风险降低相关(HR 0.86,95%CI 0.75-0.98)。
- 因类风湿关节炎的关节置换风险降低(HR 0.77,95%CI 0.63-0.94)。
- 因骨关节炎的关节置换风险无显著降低(HR 0.97,95%CI 0.94-1.01)。
临床怎么用
- 对类风湿关节炎患者处方高强度他汀可能有助于降低关节置换风险,但需结合个体化评估。
- 骨关节炎患者使用他汀未显示降低关节置换风险,不应以此为目的处方他汀。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Statins are reported to have a potential benefit on progression of OA and on disease activity in RA, but existing evidence is conflicting. Our objective was to examine whether statins associate with reduction in the risk for joint replacement due to OA and RA. METHODS: This was a propensity score-matched cohort study. Electronic health records from the UK Clinical Practice Research Datalink were used. We selected people prescribed statins and people never prescribed statins. Each statin user was matched to a non-user by age, gender, practice and propensity score for statin prescription. The main outcome measures were knee or hip joint replacement overall, and specifically because of OA or RA. The association between statins and risk of joint replacement was assessed using Cox proportional hazard regression. Statin exposure was categorized according to the potency of reducing low-density lipoprotein as low (21-28%), medium (32-38%) or high (42-55%) intensity. RESULTS: A total of 178 467 statin users were matched with 178 467 non-users by age, gender, practice and propensity score. Overall, statin was not associated with reduced risk of knee or hip replacement (hazard ratio 0.99, 95% CI: 0.97, 1.03), unless prescribed at high strength (0.86, 0.75-0.98). The reduced risk was only observed for joint replacement due to RA (0.77, 0.63-0.94) but not OA (0.97, 0.94-1.01). CONCLUSION: Statins at high intensity may reduce the risk of hip or knee replacement. This effect may be RA specific. Further studies to investigate mechanisms of risk reduction and the impact in people with RA are warranted.
引用
- Sarmanova A, Doherty M, Kuo C, et al. Statin use and risk of joint replacement due to osteoarthritis and rheumatoid arthritis: a propensity-score matched longitudinal cohort study. Rheumatology (Oxford). 2020. PMID: 32097491. doi:10.1093/rheumatology/keaa044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。